← Leaderboards
Steven A Belinsky
Lovelace Biomedical &Environmental Res
$50,259,629
Attributed
$55,523,304
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,523,304 · 16
By mechanism
R01$44,468,924 · 13
U01$8,134,877 · 2
P50$2,919,503 · 1
Top collaborators
- Philip Kuehl6 shared
- Yohannes Tesfaigzi4 shared
- Carmen S Tellez3 shared
- Shuguang Leng2 shared
Others in their field
Top investigators on “Malignant Neoplasm Of Lung”
- David Heimbrook · Leidos Biomedical Research, Inc.$349,639,893
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,674,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,410,512
- Norman Wolmark · Nsabp Foundation, Inc.$54,610,124
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
Research focus
Malignant Neoplasm Of LungGenesMethylationMalignant NeoplasmsResponseAffectLungSmokerGene SilencingSputumHypermethylationBaseCohortEpithelial CellsEpigenetic ProcessIn VitroPromotor (Genetics)Chronic Obstructive Airway DiseasePathway InteractionsCellsCell LineCytosineLinkCancer Risk
Grant awards (84)
Impact of Macrophage Carbon Load and Epigenetic Aging on Lung Function Decline and Mortality$712,649
R01 · FY2025 · ES
Impact of Macrophage Carbon Load and Epigenetic Aging on Lung Function Decline and Mortality$747,121
R01 · FY2024 · ES
DNA Repair Capacity Assays for Lung Disease Risk Assessment$806,066
U01 · FY2022 · CA · contact PI
Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats$636,893
R01 · FY2022 · ES · contact PI
DNA Repair Capacity Assays for Lung Disease Risk Assessment$832,058
U01 · FY2021 · CA · contact PI
Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats$652,940
R01 · FY2021 · ES · contact PI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy$475,810
R01 · FY2021 · CA · contact PI
DNA Repair Capacity Assays for Lung Disease Risk Assessment$776,004
U01 · FY2020 · CA · contact PI
Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats$660,000
R01 · FY2020 · ES · contact PI
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure$638,624
R01 · FY2020 · ES · contact PI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy$288,303
R01 · FY2020 · CA · contact PI
DNA Repair Capacity Assays for Lung Disease Risk Assessment$139,205
U01 · FY2020 · CA · contact PI
DNA Repair Capacity Assays for Lung Disease Risk Assessment$56,346
U01 · FY2020 · CA · contact PI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy$833,431
R01 · FY2019 · CA · contact PI
DNA Repair Capacity Assays for Lung Disease Risk Assessment$812,106
U01 · FY2019 · CA · contact PI
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure$646,355
R01 · FY2019 · ES · contact PI
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium$545,000
R01 · FY2019 · DE · contact PI
DNA Repair Capacity Assays for Lung Disease Risk Assessment$832,911
U01 · FY2018 · CA · contact PI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy$752,970
R01 · FY2018 · CA · contact PI
Histone Methyltransferases as a Target for Lung Cancer Prevention$731,519
R01 · FY2018 · CA · contact PI
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure$654,000
R01 · FY2018 · ES · contact PI
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium$545,000
R01 · FY2018 · DE · contact PI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy$850,753
R01 · FY2017 · CA · contact PI
Histone Methyltransferases as a Target for Lung Cancer Prevention$778,686
R01 · FY2017 · CA · contact PI
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium$545,000
R01 · FY2017 · DE · contact PI
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy$759,575
R01 · FY2016 · CA · contact PI
Histone Methyltransferases as a Target for Lung Cancer Prevention$567,957
R01 · FY2016 · CA · contact PI
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium$545,000
R01 · FY2016 · DE · contact PI
Histone Methyltransferases as a Target for Lung Cancer Prevention$581,472
R01 · FY2015 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$916,990
R01 · FY2014 · CA · contact PI
Epigenetic Changes Link COPD and Lung Cancer$750,856
R01 · FY2014 · CA
Histone Methyltransferases as a Target for Lung Cancer Prevention$576,204
R01 · FY2014 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$899,243
R01 · FY2013 · CA · contact PI
Epigenetic Changes Link COPD and Lung Cancer$749,117
R01 · FY2013 · CA
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection$563,530
P50 · FY2013 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$968,202
R01 · FY2012 · CA · contact PI
Epigenetic Changes Link COPD and Lung Cancer$807,435
R01 · FY2012 · CA
Genetic and Epigenetic Biomarkers for SCC of the Lung$677,372
R01 · FY2012 · ES · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$587,466
R01 · FY2012 · CA · contact PI
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection$499,864
P50 · FY2012 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$1,213,297
R01 · FY2011 · CA · contact PI
Epigenetic Changes Link COPD and Lung Cancer$849,498
R01 · FY2011 · CA
Genetic and Epigenetic Biomarkers for SCC of the Lung$677,372
R01 · FY2011 · ES · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$591,792
R01 · FY2011 · CA · contact PI
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection$544,818
P50 · FY2011 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$1,402,455
R01 · FY2010 · CA · contact PI
Genetic and Epigenetic Biomarkers for SCC of the Lung$704,377
R01 · FY2010 · ES · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$695,549
R01 · FY2010 · CA · contact PI
Tumor Suppressor Gene Methylation in Lung Adenocarcinoma$630,707
R01 · FY2010 · ES · contact PI
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection$517,485
P50 · FY2010 · CA · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$1,212,592
R01 · FY2009 · CA · contact PI
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection$793,806
P50 · FY2009 · CA · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$751,952
R01 · FY2009 · CA · contact PI
Genetic and Epigenetic Biomarkers for SCC of the Lung$671,875
R01 · FY2009 · ES · contact PI
Tumor Suppressor Gene Methylation in Lung Adenocarcinoma$621,892
R01 · FY2009 · ES · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$221,559
U01 · FY2009 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$895,885
U01 · FY2008 · CA · contact PI
Genetic and Epigenetic Biomarkers for SCC of the Lung$717,152
R01 · FY2008 · ES · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$661,128
R01 · FY2008 · CA · contact PI
Tumor Suppressor Gene Methylation in Lung Adenocarcinoma$604,386
R01 · FY2008 · ES · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$897,546
U01 · FY2007 · CA · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$655,631
R01 · FY2007 · CA · contact PI
Tumor Suppressor Gene Methylation in Lung Adenocarcinoma$641,352
R01 · FY2007 · ES · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$899,678
U01 · FY2006 · CA · contact PI
Tumor Suppressor Gene Methylation in Lung Adenocarcinoma$659,957
R01 · FY2006 · ES · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$655,955
R01 · FY2006 · CA · contact PI
Biomarkers to Assess Selenium Chemoprevention for NSCLC$405,000
R01 · FY2006 · CA · contact PI
Factors for Epigenetic Silencing of Lung Cancer Genes$965,513
U01 · FY2005 · CA
Gene Methylation and Therapeutic Response in Lung Cancer$655,842
R01 · FY2005 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC$650,829
R01 · FY2005 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC$405,000
R01 · FY2005 · CA
Factors for Epigenetic Silencing of Lung Cancer Genes$920,685
R01 · FY2004 · CA
Gene Methylation and Therapeutic Response in Lung Cancer$636,737
R01 · FY2004 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC$631,917
R01 · FY2004 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC$405,000
R01 · FY2004 · CA
Gene Methylation and Therapeutic Response in Lung Cancer$618,196
R01 · FY2003 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC$614,592
R01 · FY2003 · CA
Gene Methylation and Therapeutic Response in Lung Cancer$600,190
R01 · FY2002 · CA
TUMOR SUPPRESSOR GENE METHYLATION IN LUNG ADENOCARCINOMA$277,657
R01 · FY2002 · ES
Gene Methylation and Therapeutic Response in Lung Cancer$582,730
R01 · FY2001 · CA
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM$438,510
R01 · FY2001 · CA
TUMOR SUPPRESSOR GENE METHYLATION IN LUNG ADENOCARCINOMA$235,987
R01 · FY2001 · ES
MARKERS FOR LUNG CARCINOGENESIS IN BRONCHIAL EPITHELIUM$453,532
R01 · FY2000 · CA
TUMOR SUPPRESSOR GENE METHYLATION IN LUNG ADENOCARCINOMA$235,658
R01 · FY2000 · ES